InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,180.74
(
1.03%
)
US TECH 100
17,599.60
(
1.04%
)
Dow Jones
38,852.27
(
0.46%
)
Brent Oil
83.47
(
-0.01%
)
Bitcoin
63,135.91
(
-0.03%
)

Replies to post #182996 on Biotech Values

Replies to #182996 on Biotech Values

DewDiligence

10/20/14 5:32 PM

#182997 RE: steveporsche #182996

ENTA—Co-Development Option on Next-Generation Protease Inhibitor ABT-493 Not Exercised

As predicted in #msg-107024841.

DewDiligence

10/20/14 5:36 PM

#182998 RE: steveporsche #182996

ABT-450’s 30% value share of ABBV/ENTA’s 3-DAA regimen is disappointing; my valuation model in #msg-94993406 assumed 35%, so an adjustment to the model is needed.